This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet - Summary - MDSpire

This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet

Lilly moves to acquire Kelonia, plus gene therapy for deafness approved

  • April 27, 2026

  • 6 min

Share

Objective:

To summarize recent advancements and acquisitions in CAR-T therapies and gene therapies.

Approach:
    Key Findings:
    • Lilly's acquisition aims to simplify CAR-T delivery and improve access.
    • Otarmeni shows 80% of patients achieving meaningful hearing improvement.
    • Mivocabtagene autoleucel leads to significant mobility improvements in stiff person syndrome.
    • NRTX-1001 targets overactive neural circuits in epilepsy with early promising data.
    • Cilta-cel achieves MRD negativity in all patients with high-risk smoldering multiple myeloma.
    • AIC100 shows early responses in advanced thyroid cancers with manageable safety profile.
    Interpretation:

    These developments indicate a significant shift towards innovative therapies that enhance patient access and treatment efficacy in various conditions.

    Limitations:
    • Early-phase trials may not fully predict long-term outcomes.
    • Limited patient populations in trials may affect generalizability.
    Conclusion:

    The advancements in CAR-T and gene therapies reflect a growing trend towards personalized and accessible treatments for complex diseases.

Original Source(s)

This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet

  • April 27, 2026

Related Content

UCI Health earns NAEC Level 4 Epilepsy Center certification

UCI Health has been awarded National Association of Epilepsy Centers certification as a Level 4 Epilepsy Center.

  • May 14, 2026

  • 1 min
Language Processing Persists Under Anesthesia

Intraoperative recordings suggested preserved processing of speech and auditory context during unconsciousness.

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.